RAIMONDI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 948
EU - Europa 681
AS - Asia 489
SA - Sud America 2
AF - Africa 1
Totale 2.121
Nazione #
US - Stati Uniti d'America 942
CN - Cina 462
IE - Irlanda 263
FI - Finlandia 104
IT - Italia 91
UA - Ucraina 66
DE - Germania 51
GB - Regno Unito 31
FR - Francia 20
SE - Svezia 19
IN - India 14
BE - Belgio 11
CA - Canada 6
HU - Ungheria 4
NL - Olanda 4
PL - Polonia 4
TR - Turchia 3
CH - Svizzera 2
HR - Croazia 2
KR - Corea 2
MY - Malesia 2
NO - Norvegia 2
RS - Serbia 2
RU - Federazione Russa 2
SG - Singapore 2
TH - Thailandia 2
BR - Brasile 1
CL - Cile 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
JP - Giappone 1
LV - Lettonia 1
MU - Mauritius 1
RO - Romania 1
Totale 2.121
Città #
Dublin 263
Chandler 229
Nanjing 121
Jacksonville 113
Beijing 89
Ashburn 67
Ann Arbor 57
Nanchang 52
Helsinki 46
Shenyang 44
Princeton 42
Lawrence 40
Medford 38
Jiaxing 36
Wilmington 35
Changsha 31
Pavia 31
Hebei 27
Boardman 19
Hangzhou 19
New York 18
Woodbridge 15
Milan 12
Brussels 11
Shanghai 11
Tianjin 10
Norwalk 8
Verona 8
Chandigarh 6
Falls Church 6
Washington 6
Ningbo 5
Budapest 4
Formia 4
Jinan 4
Los Angeles 4
Padova 4
Seattle 4
Boston 3
Rome 3
Silea 3
Toronto 3
Auburn Hills 2
Ban Kho 2
Belgrade 2
Berlin 2
Birmingham 2
Brescia 2
Brunswick 2
Düdingen 2
Fairfield 2
Feldthurns 2
Fuzhou 2
Hanover 2
Houston 2
Kamien 2
London 2
Lucino 2
Mountain View 2
Nieuwegein 2
Orange 2
Oslo 2
Polska 2
Pune 2
Redwood City 2
Rho 2
San Francisco 2
Tappahannock 2
Victoria 2
West Jordan 2
Zagreb 2
Ankara 1
Bolu 1
Bovisio Masciago 1
Campo Largo 1
Campobasso 1
Central 1
Changchun 1
Dearborn 1
Delhi 1
East York 1
Fremont 1
Groningen 1
Guangzhou 1
Huntington 1
Indianapolis 1
Istanbul 1
Kota Kinabalu 1
Kuala Lumpur 1
Kunming 1
Lanzhou 1
Narbonne 1
Novokuznetsk 1
Oklahoma City 1
Piacenza 1
Redmond 1
Riga 1
Saint Albans 1
Singapore 1
Taizhou 1
Totale 1.638
Nome #
Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview. 98
D-strand perturbation and amyloid propensity in beta-2 microglobulin. 84
A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo 84
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis. 75
Sulfonated molecules that bind a partially structured species of beta2-microglobulin also influence refolding and fibrillogenesis. 71
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 70
DE loop mutations affect beta2-microglobulin stability and amyloid aggregation 68
Fluorescence detection of fibrillar proteins on silicon microstructures 67
Capillary electrophoresis analysis of different variants of the amyloidogenic protein β2 -microglobulin as a simple tool for misfolding and stability studies 66
Evaluation of capillary electrophoresis-mass spectrometry for the analysis of the conformational heterogeneity of intact proteins using beta2-microglobulin as model compound 66
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 64
Class I Major Histocompatibility Complex, the Trojan horse for secretion of amyloidogenic β2-microglobulin. 63
{beta}2-microglobulin is potentially neurotoxic, but the blood brain barrier is likely to protect the brain from its toxicity. 60
Citrate-stabilized gold nanoparticles hinder fibrillogenesis of a pathological variant of β2-microglobulin 59
The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. 57
Enhanced toxicity of silver nanoparticles in transgenic Caenorhabditis elegans expressing amyloidogenic proteins 55
Effect of tetracyclines on the dynamics of formation and destructuration of {beta}2-microglobulin amyloid fibrils. 54
Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS 53
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis 53
In situ characterization of protein aggregates in human tissues affected by light chain amyloidosis: a FTIR microspectroscopy study 51
Plasminogen activation triggers transthyretin amyloidogenesis in vitro 51
Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I. 51
The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. 50
Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis. 50
Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel. 47
Native-unlike long-lived intermediates along the folding pathway of the amyloidogenic protein beta2-microglobulin revealed by real-time two-dimensional NMR. 46
C. elegans expressing D76N β2-microglobulin: a model for in vivo screening of drug candidates targeting amyloidosis 45
A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis 44
Oleuropein aglycone: A polyphenol with different targets against amyloid toxicity 44
Human beta-2 microglobulin W60V mutant structure: Implications for stability and amyloid aggregation. 43
Embryonic stem and haematopoietic progenitor cells resist to Abeta oligomer toxicity and maintain the differentiation potency in culture 43
Recombinant amyloidogenic domain of ApoA-I: analysis of its fibrillogenic potential 42
The effects of an ideal {beta}-turn on {beta}-2 microglobulin fold stability. 39
Structure, folding dynamics and amyloidogenesis of Asp76Asn β2-microglobulin: roles of shear flow, hydrophobic surfaces and α crystallin. 38
Fibrillar amyloid peptides promote platelet aggregation through the coordinated action of ITAM- and ROS-dependent pathways 37
Properties of some variants of human beta 2- microglobulin and amyloidogenesis. 36
Increasing the accuracy of proteomic typing by decellularisation of amyloid tissue biopsies 35
The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: A possible impact on the natural history of the disease 34
Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrils 33
Historical and Current Concepts of Fibrillogenesis and In vivo Amyloidogenesis: Implications of Amyloid Tissue Targeting 31
Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between in Vitro and in Vivo Mechanisms 27
An Analysis of Ultrasound Stimulation Effects on C. Elegans Organisms Motility 18
Human wild-type and D76N β2-microglobulin variants are significant proteotoxic and metabolic stressors for transgenic C. elegans 8
Truncation of the constant domain drives amyloid formation by immunoglobulin light chains 4
Degradation versus fibrillogenesis, two alternative pathways modulated by seeds and glycosaminoglycans 1
Totale 2.215
Categoria #
all - tutte 7.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201911 0 0 0 0 0 0 0 0 0 2 3 6
2019/2020526 147 204 2 14 5 14 3 21 1 54 52 9
2020/2021179 29 17 3 16 4 19 2 30 16 23 18 2
2021/2022204 2 4 1 4 7 5 2 13 11 6 38 111
2022/2023730 78 67 2 54 69 56 0 44 315 10 12 23
2023/2024270 36 59 23 17 19 74 12 11 5 14 0 0
Totale 2.215